Stone RM - Search Results

1

Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics.

DeAngelo DJ, Stone RM, Heaney ML, Nimer SD, Paquette RL, Klisovic RB, Caligiuri MA, Cooper MR, Lecerf JM, Karol MD, Sheng S, Holford N, Curtin PT, Druker BJ, Heinrich MC. DeAngelo DJ, et al. Among authors: stone rm. Blood. 2006 Dec 1;108(12):3674-81. doi: 10.1182/blood-2006-02-005702. Epub 2006 Aug 10. Blood. 2006. PMID: 16902153 Free PMC article. Clinical Trial.

2

Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent.

Andreeff M, Stone R, Michaeli J, Young CW, Tong WP, Sogoloff H, Ervin T, Kufe D, Rifkind RA, Marks PA. Andreeff M, et al. Blood. 1992 Nov 15;80(10):2604-9. Blood. 1992. PMID: 1421378 Free article. Clinical Trial.

3

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.

Rubin EH, Andersen JW, Berg DT, Schiffer CA, Mayer RJ, Stone RM. Rubin EH, et al. Among authors: stone rm. J Clin Oncol. 1992 Jun;10(6):948-53. doi: 10.1200/JCO.1992.10.6.948. J Clin Oncol. 1992. PMID: 1588374 Clinical Trial.

4

Inhibition of phorbol ester-induced monocytic differentiation and c-fms gene expression by dexamethasone: potential involvement of arachidonic acid metabolites.

Stone RM, Imamura K, Datta R, Sherman ML, Kufe DW. Stone RM, et al. Blood. 1990 Sep 15;76(6):1225-32. Blood. 1990. PMID: 2144778 Free article.

5

A phase I study of intermittent continuous infusion high dose cytosine arabinoside for acute leukemia.

Stone RM, Spriggs DR, Dhawan RK, Arthur KA, Mayer RJ, Kufe DW. Stone RM, et al. Leukemia. 1990 Dec;4(12):843-7. Leukemia. 1990. PMID: 2243507

6

Phospholipase C activates protein kinase C and induces monocytic differentiation of HL-60 cells.

Stone RM, Weber BL, Spriggs DR, Kufe DW. Stone RM, et al. Blood. 1988 Aug;72(2):739-44. Blood. 1988. PMID: 3165300 Free article.

7

Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.

Stone RM, Maguire M, Goldberg MA, Antin JH, Rosenthal DS, Mayer RJ. Stone RM, et al. Blood. 1988 Mar;71(3):690-6. Blood. 1988. PMID: 3422828 Free article.

8

A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.

Inhorn RC, Aster JC, Roach SA, Slapak CA, Soiffer R, Tantravahi R, Stone RM. Inhorn RC, et al. Among authors: stone rm. Blood. 1995 Apr 1;85(7):1881-7. Blood. 1995. PMID: 7661940 Free article. Review.

9

Therapy with recombinant human erythropoietin in patients with myelodysplastic syndromes.

Stone RM, Bernstein SH, Demetri G, Facklam DP, Arthur K, Andersen J, Aster JC, Kufe D. Stone RM, et al. Leuk Res. 1994 Oct;18(10):769-76. doi: 10.1016/0145-2126(94)90059-0. Leuk Res. 1994. PMID: 7934135 Clinical Trial.

10

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Stone RM, Neuberg D, Soiffer R, Takvorian T, Whelan M, Rabinowe SN, Aster JC, Leavitt P, Mauch P, Freedman AS, et al. Stone RM, et al. J Clin Oncol. 1994 Dec;12(12):2535-42. doi: 10.1200/JCO.1994.12.12.2535. J Clin Oncol. 1994. PMID: 7989927

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

546 results

Search Page

Filters